0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Kidney Cancer Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
AFINITOR Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

AFINITOR Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
EUR$2,750USDGBP
Nexavar (Sorafenib) - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Nexavar (Sorafenib) - Drug Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
EUR$2,750USDGBP
Kidney Cancer Therapeutics & Diagnostics Market Analysis & Forecast 2024-2034: Market By Cancer Type; By Component (Drugs (Therapeutic Class Pharmacologic Class, Diagnostics; By End-user; and By Region - Product Thumbnail Image

Kidney Cancer Therapeutics & Diagnostics Market Analysis & Forecast 2024-2034: Market By Cancer Type; By Component (Drugs (Therapeutic Class Pharmacologic Class, Diagnostics; By End-user; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
EUR$3,150USDGBP
Kidney Cancer Therapeutics and Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029 - Product Thumbnail Image

Kidney Cancer Therapeutics and Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • Report
  • February 2024
  • 140 Pages
  • Global
From
EUR$4,750USDGBP
Middle East and Africa Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Middle East and Africa Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 90 Pages
  • Africa, Middle East
From
EUR$4,750USDGBP
Japan Renal Cancer Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Thumbnail Image

Japan Renal Cancer Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • September 2024
  • 82 Pages
  • Japan
From
EUR$3,500USDGBP
Japan Kidney Cancer Drugs Market, By Region, Competition, Forecast and Opportunities, 2020-2030F - Product Thumbnail Image

Japan Kidney Cancer Drugs Market, By Region, Competition, Forecast and Opportunities, 2020-2030F

  • Report
  • August 2024
  • 80 Pages
  • Japan
From
EUR$3,500USDGBP
Kidney Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Kidney Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • October 2023
  • 190 Pages
  • Global
From
EUR$4,500USDGBP
Europe Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Europe Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 68 Pages
  • Europe
From
EUR$4,750USDGBP
Capecitabine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Capecitabine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 121 Pages
  • Global
From
EUR$4,750USDGBP
Wilms Tumor Protein Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Wilms Tumor Protein Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 86 Pages
  • Global
From
EUR$4,013USDGBP
Diabetic Nephropathy (DN) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Diabetic Nephropathy (DN) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • August 2023
  • 76 Pages
  • Global
From
EUR$3,495USDGBP
IgA Nephropathy (Berger's Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

IgA Nephropathy (Berger's Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • August 2023
  • 72 Pages
  • Global
From
EUR$3,495USDGBP
Renal Cell Carcinoma: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Renal Cell Carcinoma: Global Drug Forecast and Market Analysis to 2028

  • Report
  • February 2020
  • 160 Pages
  • Global
From
EUR$14,995USDGBP
Renal Cell Carcinoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape - Product Thumbnail Image

Renal Cell Carcinoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape

  • Report
  • May 2022
  • 75 Pages
  • Global
From
EUR$3,495USDGBP
US Renal Cell Carcinoma Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Renal Cell Carcinoma Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
EUR$1,940USDGBP
US Diabetic Nephropathy Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Diabetic Nephropathy Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
EUR$1,940USDGBP
Global Renal Cell Carcinoma Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Renal Cell Carcinoma Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
EUR$1,090USDGBP
Global Diabetic Nephropathy Market and Competitive Landscape - 2021 - Product Thumbnail Image

Global Diabetic Nephropathy Market and Competitive Landscape - 2021

  • Report
  • August 2021
  • Global
From
EUR$3,990USDGBP
Global Renal Cell Carcinoma Epidemiology and Patient Flow - 2021 - Product Thumbnail Image

Global Renal Cell Carcinoma Epidemiology and Patient Flow - 2021

  • Report
  • February 2021
  • Global
From
EUR$2,960USDGBP
Loading Indicator

The Kidney Cancer Drugs market is a subset of the pharmaceutical industry that focuses on the development and sale of drugs used to treat kidney cancer. These drugs are used to reduce the size of tumors, slow the growth of cancer cells, and reduce the spread of cancer to other parts of the body. Common treatments include chemotherapy, targeted therapy, immunotherapy, and surgery. The market is highly competitive, with many companies vying for market share. Major players include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and AstraZeneca. These companies are constantly researching and developing new drugs to improve the treatment of kidney cancer. Additionally, many smaller companies are also involved in the market, offering innovative treatments and therapies. Overall, the Kidney Cancer Drugs market is an important part of the pharmaceutical industry, providing treatments and therapies to improve the lives of those affected by kidney cancer. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more